Repligen
RGEN
Operating Margin for Repligen (RGEN)
Operating Margin as of April 2024 (TTM): 27.34%
According to Repligen 's latest financial reports and stock price the company's current Operating Margin is 27.34%. At the end of 2022 the company had an Operating Margin of 27.34%.
Operating Margin history for Repligen from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 27.34% | 19.4% |
| 2021 | 22.90% | 41.63% |
| 2020 | 16.17% | 67.08% |
| 2019 | 9.68% | -12.41% |
| 2018 | 11.05% | 115.28% |
| 2017 | 5.13% | -54.12% |
| 2016 | 11.18% | -30.4% |
| 2015 | 16.07% | -8.33% |
| 2014 | 17.53% | -48.08% |
| 2013 | 33.76% | 86.5% |
| 2012 | 18.10% | -11454.4% |
| 2011 | -0.16% | -99.32% |
| 2010 | -23.36% | -218.81% |
| 2009 | 19.66% | -90% |
| 2008 | 196.59% | -1615.79% |
| 2007 | -12.97% | 37.27% |
| 2006 | -9.45% | -78.75% |
| 2005 | -44.46% | -69.08% |
| 2004 | -143.77% | 119.33% |
| 2003 | -65.55% | -49.45% |
| 2002 | -129.67% | -58.5% |
| 2001 | -312.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | 26.59% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 14.17% | -48.17% | 🇺🇸 USA |
 General Electric GE | -1.37% | -105.01% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -29.63% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -160.78% | -688.08% | 🇺🇸 USA |
 Novavax NVAX | -149.57% | -647.07% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 14.36% | -47.48% | 🇺🇸 USA |
 Bio-Techne TECH | 27.25% | -0.33% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -82.33% | 🇺🇸 USA |
 Charles River Laboratories
CRL | 15.02% | -45.06% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.